122 related articles for article (PubMed ID: 22462781)
1. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
Ralhan R
Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
[No Abstract] [Full Text] [Related]
2. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
[TBL] [Abstract][Full Text] [Related]
3. Personalizing cancer care: updates on head and neck cancer.
de Souza JA; Cohen EE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 13 is secreted by human head and neck tumours and does not modulate their growth in vitro.
Mehrotra R
Indian J Exp Biol; 1998 Aug; 36(8):805-7. PubMed ID: 9838882
[TBL] [Abstract][Full Text] [Related]
5. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
Eibling DE; Johnson JT; Wagner RL; Su S
Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
[TBL] [Abstract][Full Text] [Related]
6. Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma.
Pries R; Thiel A; Brocks C; Wollenberg B
In Vivo; 2006; 20(1):45-8. PubMed ID: 16433027
[TBL] [Abstract][Full Text] [Related]
7. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
Carlson GW
Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
[No Abstract] [Full Text] [Related]
8. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
Haffty BG
Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
[No Abstract] [Full Text] [Related]
9. Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
Fischer CA; Jung M; Zlobec I; Green E; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
Head Neck; 2011 Feb; 33(2):267-73. PubMed ID: 20848449
[TBL] [Abstract][Full Text] [Related]
10. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
Takes RP
Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
[TBL] [Abstract][Full Text] [Related]
11. Clinical experiences in managing head and neck squamous carcinoma.
Berger W; Goldstein J; Strawberry C
Ear Nose Throat J; 1984 Dec; 63(12):591-6. PubMed ID: 6510309
[No Abstract] [Full Text] [Related]
12. Role of molecular markers in the management of head and neck cancers.
Ferreira MB; De Souza JA; Cohen EE
Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
[TBL] [Abstract][Full Text] [Related]
13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck.
Ensley JF; Maciorowski Z
Semin Oncol; 1994 Jun; 21(3):330-9. PubMed ID: 8209264
[No Abstract] [Full Text] [Related]
16. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Wakasa T; Inoue T; Kuroda M; Shibuya K; Shigehara H; Kawasaki S; Fukui K; Kishi K; Hiraki Y
Oncol Rep; 2002; 9(6):1233-6. PubMed ID: 12375026
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes.
Veness MJ; Porceddu S; Palme CE; Morgan GJ
Head Neck; 2007 Jul; 29(7):621-31. PubMed ID: 17230560
[TBL] [Abstract][Full Text] [Related]
19. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in squamous cell carcinomas of the head and neck.
Liu M; Weynand B; Delos M; Marbaix E
Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
